Prognostic and predictive markers of systemic sclerosis-interstitial lung disease in a clinical trial and long-term observational cohort

By sjmartinez • May 26, 2023

Ghuman A, Khanna D, Lin CJF, Furst DE, Raghu G, Martinez FJ, Zucchetto M, Huang S, Jennings A, Nihtyanova SI, Denton CP. Prognostic and predictive markers of systemic sclerosis-interstitial lung disease in a clinical trial and long-term observational cohort. Rheumatology (Oxford). 2023 May 25:kead234. doi: 10.1093/rheumatology/kead234. Epub ahead of print. PMID: 37228011.

Tags: Autoantigens and autoantibodies, biological therapies, biomarkers, cytokines and inflammatory mediators, interstitial lung disease, Publications, Rheumatology, scleroderma and related disorders, systemic sclerosis

Pragmatic Comparative Effectiveness Trials in Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Multiperspective Qualitative Study

Kaczorowski-Worthley A, Mudaranthakam DP, Reichuber J, Streiler C, Pandya S, Boente R, Mathai SK, Adegunsoye A, Swigris J, Volkmann ER, Solomon JJ, England BR, Matson[...]

Reduced-dose vs full-dose direct oral anticoagulants for extended treatment of venous thromboembolism: a meta-analysis of randomized controlled trials

Ahmed M, Zulfiqar E, Ashraf H, Hashmi TM, Ahmed R, Rana JS, Greene SJ, Mentz RJ, Fudim M, Fonarow GC. Reduced-dose vs full-dose direct oral[...]

Provider Attitudes and Perceptions on Using Artificial Intelligence in Colonoscopy: A Systematic Review and Meta-Analysis

Soleymanjahi S, Rajashekar N, Chung S, Grimshaw AA, Tvedt MJK, Foroutan F, Sultan S, Shung DL, Kolb JM. Provider Attitudes and Perceptions on Using Artificial[...]